Trademarkia Logo

Canada

C$
BUPLANT
ABANDONED SECTION 36

on 30 Jan 2018

Last Applicant/ Owned by

TITAN PHARMACEUTICALS INC.

400 Oyster Point Boulevard, Suite 505South San Francisco, CA 94080

US

Serial Number

1797758 filed on 26th Aug 2016

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

BUPLANT

Trademark usage description

pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained releas Read More

Classification Information


Class [005]
Pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based subdermal matrix formulation for the sustained release of drugs in the treatment of opiate addiction and pain management; pharmaceuticals, namely, implantable drug delivery system comprised primarily of a polymer-based matrix formulation for the sustained release of drugs in the treatment of central nervous system disorders and other serious and life-threatening diseases


Classification kind code

10

Mark Details


Serial Number

1797758

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 6
on 30th Jan 2018
Abandoned - Section 36
Submitted for opposition 14
on 7th Nov 2017
Default Notice Sent
Submitted for opposition 22
on 19th Apr 2017
Search Recorded
Submitted for opposition 20
on 19th Apr 2017
Examiner's First Report
Submitted for opposition 1
on 29th Aug 2016
Created
Submitted for opposition 31
on 29th Aug 2016
Formalized
Submitted for opposition 30
on 26th Aug 2016
Filed